KKUK’s Oncology Clinic Director Ilir Kurtishi has reacted after reporting that a breast cancer patient had lost his life after he was suspected of remaining for about four months without the Palbociclib drug therapy.
Kurtishi has denied claims that patients have remained for four months without this therapy because of the lack of grass at the Oncology Clinic.
The essence of Oncology explains that there are no patients left for four months without Palbociclib therapy, as it says, because of the lack of this grass in the clinic. Supply with this drug has followed the initial dynamic of hospital supplies for all patients treated at our institution, Kurtishi has declared.
His reaction comes after the organisation Rénesansaı reported that an advanced breast cancer patient had lost his life, while claiming that the lack of therapy for about four months had been followed by the appearance of new metastases in the brain.
According to the organisation, the patient had not been able to provide the drug itself, whose price is up to 1,000 and 800 euros.
Responding to these claims, Kurtishi has explained that breast cancer at metastatic stage is a complex and aggressive disease, while treatments, including Palbociclibin, target slowing its progress but do not guarantee complete ban.
In some patients, due to individual biological tumor specifications, the disease develops resistance and displays new metastases (including those in the brain) even during the time when the patient is under regular therapy, he noted.
The director of Oncology has added that the direct connection of deteriorating health conditions with a single factor, without analyzing the patient’s complete medical history, is inaccurate medically.
He has also announced that the QKUK has contacted the organisation Rénesansa after public response.
According to Kurtish, representatives of the organisation have confirmed that the patient was facing the disease for the second time, at an advanced stage with metastase.
Kurtish has warned that information from the patient’s medical history will also be published Thursday, respecting legal provisions for privacy.
Tomorrow we’ll also publish medical history, of course maintaining all standards of privacy by law in power, where details are specified for receiving the treatment mentioned, he has stated.
In his reaction, Kurtishi has expressed condolences to the patient’s family while criticising the publication of claims that he claims may create uncertainty and concern among oncological patients and their family members.
He has stressed that the Oncology Clinic remains open for co-operation with relevant institutions to provide clarifications regarding the treatment of patients. /Telegraphy/